These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment.

The understanding of how to reduce risk factors for mental disorders has expanded remarkably as a result of recent scientific advances. This study, mandated by Congress, reviews those advances in the context of current research and provides a targeted definition of prevention and a conceptual framework that emphasizes risk reduction. Highlighting opportunities for and barriers to interventions, the book draws on successful models for the prevention of cardiovascular disease, injuries, and smoking. In addition, it reviews the risk factors associated with Alzheimer's disease, schizophrenia, alcohol abuse and dependence, depressive disorders, and conduct disorders and evaluates current illustrative prevention programs. The models and examination provide a framework for the design, application, and evaluation of interventions intended to prevent mental disorders and the transfer of knowledge about prevention from research to clinical practice. The book presents a focused research agenda, with recommendations on how to develop effective intervention programs, create a cadre of prevention researchers, and improve coordination among federal agencies.

This groundbreaking volume thoroughly explores the intriguing and sometimes baffling phenomenon of positive adaptation to stress by children who live under conditions of extreme vulnerability. Examining the determinants of risk, the development of competence in the midst of hardship, and the nature of stress-resilience, THE INVULNERABLE CHILD will be of profound interests to psychiatrists, developmental and clinical psychologists, social workers, nurses, educators and social scientists, and all those involved in the psychosocial well being of children.

The content of "Diagnostic criteria for research" (DCR-10) is derived from chapter V(F), Mental and behavioural disorders, of ICD-10 [International Statistical Classification of Diseases and Related Health Problems, tenth revision]

This volume reviews the latest information about the treatment and prevention of major mental disorders that emerge during adolescence. It should be a primary resource for both clinicians and researchers, with special attention to gaps in our knowledge.

The book provides a comprehensive overview of neurodevelopmental disorders comprising motor, speech, cognitive and behavioral dysfunctions. Childhood and adolescent disorders ranging from dyslexia to schizophrenia and including autism, motor disorders and the attention deficit hyperactivity syndrome are presented from the perspectives of genetics, developmental psychology, clinical neurology and psychiatry. A multiprofessional team of experts from the various fields has contributed to this volume, which is aimed at clinicians and researchers alike. The reader will find up to date coverage of the clinically most relevant neurodevelopmental disorders with regard to pathophysiology, clinical presentation and treatment.

An international team of experts review the latest findings in the diagnosis and treatment of schizophrenia in the young.

Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.